chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Received vaccine at 0930 and was dismissed from waiting area at 0946 with no symptoms or reactions.  My husband and I stopped to do some errands on way home (car wash and store). We returned home  at 11:30 AM when I experienced pruritis and fatigue.  I looked at chest and abdomen and noted  reddened rash. My husband also noted rash on my back.  I went to sleep for 2 hours after taking a 25  mg. diphenhydramine tablet. When I awoke my husband confirmed I had urticaria all over the trunk of  my body and extending to my knees, elbows and chin line.l had severe pruritis with this We had family  arriving for a visit that evening (4/23), so I continued taking diphenhydramine 25mg and alternating  with Hydroxyzine 25 mg. for
pt presented to hosp in febrile status epilepticus on the evening of 27FEB95 p/receiving vaccines same day;
My left eye was red and itchy. My left eyelid had some swelling.  Used artificial tear drops, took one Pepcid, took one Bendaryl. Redness and swelling went away within 3 hours.
After vaccination patient claimed she feels dizzy so we told her to sit for monitoring .  After 15 min she still felt dizzy so we measure her blood pressure which was really elevated ( 190/110 , 185/100 ) . We asked if she has history of hypertension which she denied . She claims she was feeling fine and that vaccine caused this reaction . She denied being on any medication . We offered to call 911 to take her to hospital but she asked her sister to pick her up and take her to ER.
Pt experienced a severe rash on face and a headache 12 - 13 hours post vax.
Pt developed macular rash, arms, neck, trunk and back involved. No itching; some slightly papular. Temp 98.6. Additional information. I took 50mg Benadryl the night after I made the report. The rash was completely gone the next day.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Nurse). The reporter is the patient.  A 40-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 23Jun2021 as dose 1, single (Lot number: EW0173) and on 14Jul2021 as dose 2, single (Lot number: EW0186) at the age of 39 years for covid-19 immunisation. The patient's relevant medical history included: "Lupus" (unspecified if ongoing); "mvp" (unspecified if ongoing); "svt" (unspecified if ongoing); "migraines" (unspecified if ongoing); "h/o Lyme disease" (unspecified if ongoing); "Epstein Barr" (unspecified if ongoing). Concomitant medication(s) included: PLAQUENIL [HYDROXYCHLOROQUINE SULFATE].  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 antibody test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Treatment included was :Anti-viral details: COVID 19 Treatment, brand: Paxlovid, treatment started on 09Jul2022, treatment stopped on 11Jul2022. Patient took Other medication in 2weeks was Plaquenil. Other Known allergies was not reported. Other medical history reported were Lupus, mvp, svt, migraines , h/o Lyme disease and Epstein Barr.; Sender's Comments: As there is limited information in the case provided, the causal association between the reported events drug ineffective  and Covid-19 and the suspect drug cannot be excluded. The case will be reassessed once new information is available.
Low back pain, fever, chills, shakes, headache, nausea/vomit, fatigue
Client received flu vaccination 10/2/18 at 8:35 AM and reported feeling more pain than normal with injection. At 12:00 PM she reports feeling increased soreness with movement. 10/3/18 Started Ibuprofen 400 mg Q4H and ice pack to L arm for increased pain in her shoulder in the AM. 10/4/18 States that the pain has worsened and is now moving from the shoulder to the elbow. 10/5 no change. 10/6/18 States that pain has not improved and is now noticing pain, numbness, and tingling sensations in the pinky finger and ring finger of her L hand. 10/7/18 States that the tingling and numbness have spread to her jaw, teeth, cheek, and L eye. "It feels like it does after the dentist". 10/8/18 Examined by PCP/NP. NP states no weakness in her L arm/hand and her ROM is still WNL. She was instructed to rest, and continue to ice. If no improvement or Sx's worsen to call back for appt. 10/10/18 Client increased Ibuprofen to 600 mg Q8H and she has continued to rest and ice. When talking to me she also stated she is having some numbness and tingling in her L leg and foot. I advised her to make appt. with her PCP for possible PT in the future and possible referral to neurologist. Advised I would file VAERS report and monitor her progress.  Client was appreciative of call and follow up.
A report has been received from a Health Professional concerning a 20 year old, Female subject, who had been receiving Nasal FLUMIST (intranasal). FLUMIST (intranasal) started on 17-Sep-2013. The patient was administered two full doses of FLUMIST, one in each nostril which started on 17-Sep-2013. The outcome of the event of two full doses of FLUMIST, one in each nostril is unknown. The report was considered to be non-serious.
Pt went to the local public library and obtained administration of the flu vac. Became sick H/A, light headed, diarrhea, spent 10 days in bed was advised she had the flu(was eval by urgent care) and given TAMIFLU.
@ 1623 Pt felt a little lightheaded and might pass out.  Completed monitoring and was in hall scheduling second appointment when symptoms started.  Fireman at site.  @ 1627 BP 123/72, HR 59, RR 12, easy un-labored.  PT states feels better.  States he had symptoms before when overwhelmed.  @ 1640 BP 120/74, HR 62.  @1640 Ready to leave.  States this happens to him when he is nervous.  No longer feels anxious.  No symptoms at this time.  @ 1643 PT states he is asymptomatic and he can drive home.  Instructed to call 911 if any symptoms with driving and to pull over.  Advised to seek medical care if any symptoms.  Pt verbalized understanding. Pt oriented x 4.  Pt walked out by himself.
facial swelling in areas where I previously had facial fillers mostly in the temple and eyes. greater swelling in the right eye
I had a lot of nasal congestion, cough, low grade fever, chills, and extreme fatigue. The next morning I took a COVID-19 test at home and it was positive. A few days later I had a telemedicine visit with a doctor, and I was prescribed Paxlovid. My symptoms lasted about 5 days. The only lingering symptom is fatigue because I still get tired easily.
Fatigue Change in period- April: 3 days longer and heavier flow May: extreme cramping, nausea and heavier flow
This spontaneous report as received from a 65 year old female patient regarding herself. The patient had no medical history or drug reactions/allergies. The patient's concurrent conditions were not reported. On an unspecified date in 2012, the patient was vaccinated with a dose of ZOSTAVAX injection, in the left shoulder, (dose, frequency, lot number and expiration date were not reported). The patient had no concomitant medications. No product quality complaint (PQC) was involved. On an unspecified date in 2016, the patient got an out break and experienced rash on her hip. On an unspecified date the patient sought medical attention and an unspecified treatment was given to treat the rash. No laboratory studies were performed. At the time of the report the outcome of the rash was unknown. The reporter did not provide the causal relationship between ZOSTAVAX and the rash. Additional information is not expected as no contact details were provided.
Malaise, flu like body aches, low grade temp and headache.  Followed by a papular (1 mm papules) red rash on palms, then extensor surface of hands/knees/elbows (nowhere else).  Somewhat pruritic.  Bilateral arthralgias in joints, but mostly in hands.
This case was reported by a pharmacist via call center representative and described the occurrence of vaccination failure in a adult patient who received SHINGRIX for prophylaxis. Co-suspect products included SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX and the 2nd dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX and SHINGRIX, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to SHINGRIX and SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient had possible outbreak of shingles after 2nd inoculation and needed guidance if this could occurred and asked about treatment. The call was foldered by the fulfillment specialist for a call back to HCP, was not able to reach HCP till the time of reporting. Sender forwarded/send the details to the patient safety with the questions that was posed to MI for assistance. This case was considered as the suspected vaccination failure since the exact time to onset for the event was not provided.
In the middle of the night of the day I got the shot- I woke up with an aching back. Then I woke up early morning hours with a terrible headache. When I got up in morning, I was stiff and achy all over. My hips and back really ached. I came home from work at lunchtime, I was totally exhausted. I stayed on the sofa for rest of the Wednesday and Thursday. I was so tired I could not move. It was like a bad flu. My arm had a bruise at the injection site, was very swollen, hot to touch and a red patch below injection site Thursday I woke up on the sofa and my throat was starting to get sore and a small portion of my face was numb. Numbness did not last long but sore throat got worse and I went to urgent care.
Information has been received from a physician concerning an 83 year old white female who on 08-MAY-2006 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (0.5 ML) (lot#651328/1046P), intramuscularly.  On 08-MAY-2006, "that night"  the patient experienced chills, swelling, mildly red, and throbbing pain of the right deltoid area.  On 09-MAY-2006 the patient  was seen by a physician.  On 10-MAY-2006, the patient recovered.  Additional information has been requested.
Intense shivering about 12 hours after the vaccination.  Tylenol stopped the shivering.
Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 3/28/2021 and 4/18/2021. Recent COVID infection (tested positive 12/30 per daughter) presenting with NSTEMI, new HFrEF, and acute hypoxic respiratory failure requiring AirVo in the setting of HTN urgency. Admitted for acute respiratory failure with hypoxia, pulmonary edema, and pulmonary infiltrates. Diuresed and developed worsening renal function with persistent hypoxia. Family decided to pursue comfort care and patient passed on 1/19/2022.
Erythema, fever. Enduration and erythema approx 3x4cm in upper thigh. Baby playful & happy. Probable irritative reaction, secondary infect. Ped DT should be given in future.
Patient developed lethargy, anorexia, chills, hypotension, and diarrhea on the evening he had his 3rd Moderna vaccination (5:45pm 11/07/2021). He was seen in the kidney transplant clinic at medical center for follow up. He looked ill with BP 84/48 and his labs demonstrated WBC 0.6 and ANC 0.3.  He was sent to the ED for admission and further workup.
Pt received  both doses of Moderna Jan and Feb 2021 at off-site location. Pt insisted on receiving Janssen in addition for extra coverage compared to Moderna. Explained to patient that there is no current recommendation on getting both vaccines as there is no study on safety/efficacy on getting both vaccines. Pt still wanted to receive the vaccine. Because there is no contraindication of getting both vaccines and there was not clear instructions in this situation at the time (5/19), Pt received Janssen. Report is now made as soon as  instructions was sent out by corporate regarding similar situations. Pt was counseled to monitor on potential side effects of both vaccines. No adverse reactions reported as of 5/28/21.
The pt received Lymerix on 6/4/99 and 7/9/99. In early September, 1999, he experienced an onset of symptoms described as "all joints could not bend" and heat, swelling and "constant pain, 24 hours a day". On 10/29/2000, pt reported a sudden onset of right medial foot discomfort starting about the end of August, 1999. He was told it was related to an old fracture. Soon thereafter, he developed shoulder, back and leg soreness. He noted inflammation with significant swelling and pain involving hand joints, wrists, left shoulder and elbows. He also noted pain and swelling involving his knees and metatarsal phalangeal joints of both feet. He additionally, complained of decreased energy level and morning stiffness. Impression was that the pt had "probable new onset rheumatoid arthritis" as the pt had polyarticular small and large joint symmetrical synovitis of the upper and lower extremities with a positive rheumatoid factor. Rheumatologist thought this was unlikely. Activities of daily living were noted to be hampered (could not grip hammer). He was continued on Celebrex. 11/3/99, visit with 2nd Rheumatologist: 3 weeks ago, fairly acute onset of fevers up to 101F, associated with swelling and pain of his right knee, which progressed to his left knee, also, had severe joint pain in his shoulders and various small joints of his hands. Pt seen by an Orthopedist. 11/18/99, dx'd with "seropositive rheumatoid arthritis". Pt had dramatic response to aspiration and injection of knee. 11/29/99, pt felt to have rheumatoid arthritis and possibly inflammatory osteoarthritis, so prednisone increased. Morning stiffness and has not been able to return to work. 1/3/00, synovial thickening of wrists and some hand joints, right knee effusion. 2/21/00, dx is seropositive rheumatoid arthritis of 4 months duration, unable to taper prednisone below 15 mg. Methotrexate 7.5mg added. This case is considered serious because the pt has been disabled, since he has been out of work. The most recent information received on 6/26/00 reports the outcome of the events as persisting. Latest FU states the pt has been determined to have the gene for rheumatoid arthritis.
After 8 days my arm started hurting. It has red welts on it and feels hot. Today is day 10 and it?s redder than before.
This spontaneous report as received from a registered nurse refers to a patient of unknown age. On 06-MAR-2013 the patient was vaccinated with PROQUAD (merck) (lot number not provided) 0.5 ml once, subcutaneous. The PROQUAD (merck) had been stored in the refrigerated at 4-5 degrees C. for 384 hours. No adverse effect reported. Additional information has been requested.
She has been noticing tingling involving all her extremities, initially intermittently and now progressing to constant numbness/tingling, after the second shot of COVID 19 vaccine . Symptoms started may be a few days after the 2nd COVID 19 vaccine.
Tachycardia with her heart rate in the 140s; Felt flushed; A spontaneous report was received from  consumer concerning a  female patient, who was administered Moderna's COVID-19 vaccine, and experienced tachycardia with her heart rate in the140s and felt flushed.  The patient's medical history was not provided. No relevant concomitant medications were reported.   On 27 Feb 2021, the patient received their first of two planned doses of mRNA-1273 (Lot: unknown) intramuscularly for prophylaxis of COVID-19 infection.  On 27 Feb 2021, Saturday at 12pm and then at 8 pm, the patient experienced tachycardia with her heart rate in the140s and felt flushed. She is wondering if that's from the vaccine and if she should get the second vaccine. No treatment information provided.   The outcome of the events, tachycardia with her heart rate in the 140s and felt flushed, were unknown.; Reporter's Comments: Based on the current available information, a strong temporal association between the use of the product and the start date of the events, a causal relationship with the events cannot be excluded.
14 dead relatives and friends that took that; This case was reported by a consumer via interactive digital media and described the occurrence of unknown cause of death in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced unknown cause of death (serious criteria death and GSK medically significant). On an unknown date, the outcome of the unknown cause of death was fatal. The reported cause of death was unknown cause of death.   It was unknown if the reporter considered the unknown cause of death to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 7-Jul-2022 Reporter's Comments: This case was reported by a patient's relative or friend via interactive digital media. The reporter reported that she/he had 14 dead relatives and friends that took that crap poison (Shingles vaccine). Additional Supportive Information:  The follow-up would not possible as no contact details were available. This case is 1 of 16 cases reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR104784:Same reporter US-GLAXOSMITHKLINE-US2022AMR104786:Same reporter US-GLAXOSMITHKLINE-US2022AMR104785:Same reporter US-GLAXOSMITHKLINE-US2022AMR104782:Same reporter US-GLAXOSMITHKLINE-US2022AMR104793:Same reporter US-GLAXOSMITHKLINE-US2022AMR104789:Same reporter US-GLAXOSMITHKLINE-US2022AMR104787:Same reporter US-GLAXOSMITHKLINE-US2022AMR104773:Same reporter US-GLAXOSMITHKLINE-US2022AMR104795:Same reporter US-GLAXOSMITHKLINE-US2022AMR104796:Same reporter US-GLAXOSMITHKLINE-US2022AMR104797:Same reporter US-GLAXOSMITHKLINE-US2022AMR104799:Same reporter US-GLAXOSMITHKLINE-US2022AMR104801:Same reporter US-GLAXOSMITHKLINE-US2022AMR104876:Same reporter US-GLAXOSMITHKLINE-US2022AMR104854:Same reporter; Reported Cause(s) of Death: Unknown cause of death
This case was reported by a healthcare professional and described the occurrence of erythema in a 5-year-old male subject who was vaccinated with Infanrix (GlaxoSmithKline) for prophylaxis. Concurrent vaccination included live attenuated measles, mumps and rubella vaccine (right arm), live attenuated oral poliomyelitis vaccine (left arm) and varicella virus vaccine (right arm) all given on 26 March 2007, same day as the 5th dose of Infanrix. On 26 March 2007, the subject received 5th dose of Infanrix at 0.5 mL in the left arm. On 28 March 2007, two days after the 5th dose of Infanrix, the subject experienced erythema, swelling and warm to touch at the site of injection. The subject was treated with Benadryl. At the time of reporting the outcome of the events was resolved. The healthcare professional considered the events were related to vaccination with Infanrix. Follow-up information received on 30 March 2007 indicated that the events were improved. The reporter expressed concern over this lot of Infanrix causing the events.
Information has been received from a 64 year old female who is a nurse with a cashew allergy, dilauid allergy and iodine (IVP) allergy who in 1995 was vaccinated IM with a second dose of Recombivax HB. Concomitant medication included an unspecified thyroid medication and Motrin IB. An allergic reaction was noted of chills, fever, abdominal pain and ill like malaise that lasted a few days. She did not receive the third injection. The series was again tried in 1997 and after the first dose in that series of Recombivax HB the patient just felt tired with no other symptoms. The second dose of that series was followed by chills, fever, abdominal pain and swelling. She did not continue the series. It was noted that she was trying to determine if this brought on all her allergies: amoxil, penicillin, Ceclor (hospitalized for hives), Keflex (red rash), albuterol, dopamine, novocaine with epinephrine, Benadryl, IM, heparin drip, B 12 injection and latex. Allergy tests were done and determined she was allergic to shellfish, wheat, barley, bananas and nuts. It was also reported that she experienced a rash while taking antibiotics, cortisone, IVP dyes, iodine, Keflex, Amoxil, Visine and latex and that Glucophage makes her nauseous. Information received contained the following adverse experiences: polymyalgia and breast cancer. Additional information has been requested.
On the morning of May 22, 2021, I awoke with a severe nosebleed?the first of many that I would have this past summer?and all involving my left nasal passage. Two subsequent nosebleeds, on July 17 on August 22, required trips to the Emergency Department followed by visits to an ENT doctor. On the first ED visit, they had to pack my nose with a rhino-pack because the bleeding would not stop. On the second visit (I was there for several hours), the bleeding eventually stopped using the nasal clamp I was given. In both instances I was advised to follow up with an ENT doctor. After the first ED visit, the ENT doctor that I saw performed cauterization, which seemed to work at first but clearly it was not enough, given my need to go to the ED the following month. After that second ED visit I followed up with an ENT Specialistwho performed more cauterization. He indicated that several of my blood vessels were "prominent." This was in August, and I've not had a problem since.  I am not suggesting that the COVID vaccine had anything to do with these bouts of epistaxis; however, when I responded to the last "Be Safe" text that I received from the CDC indicating these issues, I was advised to report them to VAERS.
Patient received vaccination and approximately 5 minutes later fainted.  she was helped to a seated position and remained seated for several minutes until able to be helped into a chair.  She then stayed seated in the chair under observation for about 20 minutes and returned to a normal general state and was able to be escorted out of the pharmacy to their ride.
12/21/21 presents to EC ED for "cough and fevers". PMHx of "HLD, OSA, Lung CA s/p resection (2018), and COPD."
Felt achy and arm was sore.  Later the next day, my arm was swollen and very sore.  Other parts of my body are no aching.  Three days later, my arm is very sore and swollen.
Custodial grandmother states that client became disoriented in hallway outside of clinic and went to the ground just inside the front door to the building. Grandmother states that client did not fall but was lowered to the ground. She did not bump her head and no other injury occurred. Patient was ambulatory back to the clinic. She was pale and diaphoretic. Laid client down and gave water and crackers. She waited fifteen minutes. Color and behavior returned to normal. Client was escorted back to the front door.
Large area of arm red and swollen and warm. Reaction worsened on day 2 after vaccine. Pt sought treatment at E.R. Treated as allergy and infection. Prescribed MEDROL dose pack and BENADRYL for allergy and CLEOCIN 300 mg QID x 7d for infection.
Patient was given expired Pfizer vaccine. The vial was punctured/mixed at 8:15 am on 05/13/2021, expired 6 hours later at 2:15pm, vaccine was given 4:02pm
Moderate Fatigue, Headache, Indigestion. Rash on my left arm where got the shot with moderate pain